The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

APH ALLIANCE PHARMA PLC ORD 1P




 Page 2 of 2

Previous | 1 | 2 |

Time/Date Code Headline Source Impact
15:27 18-Dec-2014 APH Directorate Change RNS +3.59% Up
07:00 10-Sep-2014 APH Alliance Pharma PLC Interim Results RNS -2.36% Down

 Page 2 of 2

Previous | 1 | 2 |



Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.

Market

Company Information
Updated Monthly
Company address Avonbridge House, 2 Bath Road, Chippenham, SN15 2BB, United Kingdom
Company website http://www.alliancephar...
Market cap(in millions)* £ 147.88
Listing/Admission to trading 23 Dec 2003
Trading service SEAQ
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
02-Sep-15
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment AIM
MiFID Status MTF
Exchange market size 7,500
SEDOL 3103081
ISIN number GB0031030819



ALLIANCE PHARMA share - news analysis